The table below shows Co-Diagnostics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$622.49K
$3.92M
$6.81M
$34.22M
$97.89M
$74.55M
Cost of revenue
$222.38K
$999.12K
$4.18M
$5.48M
$11.57M
$16.59M
Gross profit
$400.11K
$2.92M
$2.63M
$28.74M
$86.31M
$57.96M
R&D
$19.14M
$20.98M
$22.96M
$17.44M
$14.96M
$3.19M
CODX annual revenue (10-K history)
Co-Diagnostics, Inc. reported annual revenue of $622.49K for fiscal year 2025. That is down 84.1% from $3.92M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $7.66K (FY 2017) to $622.49K. Figures come from the company's audited annual reports as filed with the SEC.